Intrinsiqq
Biodesix Inc. logo

Biodesix Inc. (BDSX) Insider Trading

Last 12 months

Insiders sold $118k and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Chief Accounting Officer Chris Vazquez sold $3k on Feb 23, 12% of their stake, outside a plan. The last open-market buy by an executive or director was in Sep 2025.

Net open-market
−$118k
0 buys · 20 sales
Under a 10b5-1 plan
0%
of the value sold
Insiders who bought / sold
0 / 5
executives and directors
Last open-market buy
Sep 2025
Sep 19, 2025

Get an email when BDSX's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Aug 12
    Jack W Schuler
    Large holder · bought 15,000 at $24.47
    $367k
    0.6% of stake
  • Aug 10 – 11
    Jack W Schuler
    Large holder · bought 27,600 at avg $24.13
    $666k
    1.2% of stake
  • Feb 23No plan
    Chris Vazquez
    Chief Accounting Officer · sold 211 at $12.78
    $3k
    12% of stake
  • Feb 23No plan
    Robin Harper Cowie
    CFO, Sec'y & Treasurer · sold 535 at $12.78
    $7k
    3.2% of stake
  • Feb 23No plan
    Scott Hutton
    President & CEO · sold 1,490 at $12.78
    $19k
    3.0% of stake
  • Feb 23No plan
    Gary Anthony Pestano
    Chief Development Officer · sold 556 at $12.78
    $7k
    5.1% of stake
  • Feb 23No plan
    Kieran O'Kane
    Chief Commercial Officer · sold 535 at $12.78
    $7k
    5.2% of stake
  • Feb 10No plan
    Robin Harper Cowie
    CFO, Sec'y & Treasurer · sold 941 at $10.08
    $9k
    5.8% of stake
  • Feb 10No plan
    Chris Vazquez
    Chief Accounting Officer · sold 101 at $10.08
    $1k
    7.6% of stake
  • Feb 10No plan
    Kieran O'Kane
    Chief Commercial Officer · sold 584 at $10.08
    $6k
    6.2% of stake
  • Feb 10No plan
    Gary Anthony Pestano
    Chief Development Officer · sold 540 at $10.08
    $5k
    5.4% of stake
  • Feb 10No plan
    Scott Hutton
    President & CEO · sold 3,559 at $10.08
    $36k
    7.3% of stake
  • Jan 23 – 26
    Jack W Schuler
    Large holder · bought 100,000 at avg $11.81
    $1.18M
    4.5% of stake
  • Jan 22
    Jack W Schuler
    Large holder · bought 82,465 at $10.96
    $904k
    3.9% of stake
  • Jan 16No plan
    Chris Vazquez
    Chief Accounting Officer · sold 83 at $8.15
    $676
    7.2% of stake
  • Jan 16No plan
    Gary Anthony Pestano
    Chief Development Officer · sold 298 at $8.15
    $2k
    3.4% of stake
  • Jan 16No plan
    Kieran O'Kane
    Chief Commercial Officer · sold 298 at $8.15
    $2k
    3.6% of stake
  • Jan 16No plan
    Scott Hutton
    President & CEO · sold 970 at $8.15
    $8k
    2.4% of stake
  • Jan 16No plan
    Robin Harper Cowie
    CFO, Sec'y & Treasurer · sold 298 at $8.15
    $2k
    2.1% of stake
  • Nov 10, 2025No plan
    Chris Vazquez
    Chief Accounting Officer · sold 13 at $7.62
    $99
    1.4% of stake
  • Nov 10, 2025No plan
    Gary Anthony Pestano
    Chief Development Officer · sold 23 at $7.62
    $175
    0.3% of stake
  • Nov 10, 2025No plan
    Kieran O'Kane
    Chief Commercial Officer · sold 25 at $7.62
    $191
    0.3% of stake
  • Nov 10, 2025No plan
    Scott Hutton
    President & CEO · sold 189 at $7.62
    $1k
    0.5% of stake
  • Nov 10, 2025No plan
    Robin Harper Cowie
    CFO, Sec'y & Treasurer · sold 50 at $7.62
    $381
    0.4% of stake
  • Sep 19, 2025
    Jack W Schuler
    Director · bought 142,045 at $7.04
    $1000k
    7.1% of stake
  • Sep 17, 2025 – Sep 18, 2025
    Jack W Schuler
    Director · bought 18,373 at avg $6.06
    $111k
    0.9% of stake
  • Aug 29, 2025
    Jack W Schuler
    Director · bought 3,488,372 at $0.43
    $1.5M
    9.7% of stake
  • Aug 13, 2025No plan
    Robin Harper Cowie
    CFO, Sec'y & Treasurer · sold 988 at $0.42
    $415
    0.4% of stake
  • Aug 13, 2025No plan
    Scott Hutton
    President & CEO · sold 3,772 at $0.42
    $2k
    0.5% of stake
  • Aug 13, 2025No plan
    Kieran O'Kane
    Chief Commercial Officer · sold 476 at $0.42
    $200
    0.3% of stake
  • Aug 13, 2025No plan
    Gary Anthony Pestano
    Chief Development Officer · sold 442 at $0.42
    $186
    0.3% of stake
  • Aug 13, 2025No plan
    Chris Vazquez
    Chief Accounting Officer · sold 228 at $0.42
    $96
    1.2% of stake
  • May 16, 2025 – May 19, 2025
    Jack W Schuler
    Director · bought 4,723,239 at avg $0.28
    $1.33M
    15% of stake
  • May 12, 2025 – May 13, 2025No plan
    Chris Vazquez
    Chief Accounting Officer · sold 224 at avg $0.36
    $80
    1.2% of stake
  • May 12, 2025 – May 13, 2025No plan
    Gary Anthony Pestano
    Chief Development Officer · sold 445 at avg $0.36
    $158
    0.3% of stake
  • May 12, 2025 – May 13, 2025No plan
    Kieran O'Kane
    Chief Commercial Officer · sold 477 at avg $0.36
    $169
    0.3% of stake
  • May 12, 2025 – May 13, 2025No plan
    Scott Hutton
    President & CEO · sold 3,775 at avg $0.36
    $1k
    0.5% of stake
  • May 12, 2025 – May 13, 2025No plan
    Robin Harper Cowie
    CFO, Sec'y & Treasurer · sold 992 at avg $0.36
    $352
    0.4% of stake
  • Feb 11, 2025No plan
    Chris Vazquez
    Chief Accounting Officer · sold 3,630 at $0.92
    $3k
    17% of stake
  • Feb 11, 2025No plan
    Gary Anthony Pestano
    Chief Development Officer · sold 16,748 at $0.92
    $15k
    9.7% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch BDSX, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Services-Medical Laboratories

Spot a number that looks wrong? Check it in BDSX's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing BDSX

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.